Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts

Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts

The creation of small-diameter tissue-engineered vascular grafts using biodegradable materials has the potential to change the quality of cardiovascular surgery in the future. The implantation of these tissue-engineered arterial grafts has yet to reach clinical application. One of the reasons for th...

Full description

Bibliographic Details
Main Authors:	Yuichi Matsuzaki, Anudari Ulziibayar, Toshihiro Shoji, Toshiharu Shinoka
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Applied Sciences
Subjects:	tissue-engineered vascular grafts biodegradable material anticoagulation medication heparin large-animal study
Online Access:	https://www.mdpi.com/2076-3417/11/10/4563

Similar Items

The Evolution of Tissue Engineered Vascular Graft Technologies: From Preclinical Trials to Advancing Patient Care
by: Yuichi Matsuzaki, et al.
Published: (2019-03-01)

Clinical Application for Tissue Engineering Focused on Materials
by: Takahiro Kitsuka, et al.
Published: (2022-06-01)

Timing of Heparin Administration Modulates Arterial Occlusive Thrombotic Response in Rats
by: Amanda B. Matrai, et al.
Published: (2020-03-01)

A Brief Report on an Implantation of Small-Caliber Biodegradable Vascular Grafts in a Carotid Artery of the Sheep
by: Larisa V. Antonova, et al.
Published: (2020-05-01)

Drug-eluting Vein Graft with Acetylsalicylic Acid-Ticagrelor-Unfractionated Heparin Complex Inhibits Early Graft Thrombosis
by: Ercan Akşit, et al.
Published: (2020-09-01)

In Vivo Evaluation of Gamma-Irradiated and Heparin-Immobilized Small-Diameter Polycaprolactone Vascular Grafts with VEGF in Aged Rats
by: Se-Eun Kim, et al.
Published: (2022-03-01)

Recent Developments and Current Challenges of Heparin-Grafted Hemodialysis Membranes
by: Amira Abdelrasoul, et al.
Published: (2022-08-01)

The evaluations of frequency distribution heparin resistance during coronary artery bypass graft
by: Kaivan Bagheri, et al.
Published: (2014-01-01)

Nanofibers with homogeneous heparin distribution and protracted release profile for vascular tissue engineering
by: Hongmei Zhang, et al.
Published: (2023-06-01)

Construction of tissue-engineered vascular grafts with enhanced patency by integrating heparin, cell-adhesive peptide, and carbon monoxide nanogenerators into acellular blood vessels
by: Yonghong Fan, et al.
Published: (2024-04-01)

The Application of Porous Scaffolds for Cardiovascular Tissues
by: Tatsuya Watanabe, et al.
Published: (2023-02-01)

Pharmacological properties of hirudin and its derivatives : potential clinical advantages over heparin /
by: 422288 Monreal, Manuel, et al.

Strategies to Overcome Heparins’ Low Oral Bioavailability
by: Ana Rita Neves, et al.
Published: (2016-06-01)

Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01)

Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model /
by: Walenga, J. M.

Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-relared inhibitors /
by: Brankamp, R. G.

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
by: Harry Menon, et al.
Published: (2018-10-01)

Heparin Mimetics: Their Therapeutic Potential
by: Shifaza Mohamed, et al.
Published: (2017-10-01)

Comparing the Effects of Three Heparinization Methods of Hemodialysis Set on the Amount of Clot Formation during Hemodialysis
by: M Kazemi, et al.
Published: (2005-07-01)

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin : comparison with heparin and recombinant hirudin /
by: Berry, Christopher N.

Results of preclinical trials in a sheep model of biodegradable small-diameter vascular grafts
by: L. V. Antonova, et al.
Published: (2022-09-01)

Grafting of Heparin on Blend Membrane of Citric Acid Crosslinked Chitosan/Polyethylene Glycol-Poly Vinyl Alcohol (PVA-PEG)
by: Retno Ariadi Lusiana, et al.
Published: (2019-01-01)

INTRAOPERATIVE ANTICOAGULATION MONITORIZATION IN VASCULAR SURGERY – DOES A BLIND DOSIS FITS ALL?
by: Nuno Henriques Coelho, et al.
Published: (2019-05-01)

Occurrence and structural characterization of heparin from molluscs
by: N Volpi
Published: (2005-02-01)

Occurrence and structural characterization of heparin from molluscs
by: N Volpi
Published: (2005-02-01)

Novel reinforcement of corrugated nanofiber tissue-engineered vascular graft to prevent aneurysm formation for arteriovenous shunts in an ovine model
by: Hiroshi Matsushita, MD, et al.
Published: (2022-01-01)

Off-pump coronary artery bypass grafting using continuous heparin infusion
by: Kamales Kumar Saha, et al.
Published: (2016-11-01)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01)

Recombinant Heparin—New Opportunities
by: Charles Alexander Glass
Published: (2018-12-01)

Potential targets of heparin during progression and metastasis of malignant neoplasms
by: V. V. Malashchenko, et al.
Published: (2024-01-01)

Advances in Cardiac Tissue Engineering
by: Takahiro Kitsuka, et al.
Published: (2022-11-01)

Preparation, Anticoagulant and Antioxidant Properties of Glucosamine-Heparin Salt
by: Qin Miao, et al.
Published: (2022-10-01)

The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review
by: Aleksandra Frackiewicz, et al.
Published: (2023-05-01)

Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
by: Lorenzo A. Alberio, et al.
Published: (2020-04-01)

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
by: Heloísa Antoniella Braz-de-Melo, et al.
Published: (2021-04-01)

DOES HEPARIN HAVE AN ESSENTIAL ROLE IN THE TREATMENT OF THE COVID-19 PANDEMIC? A REVIEW
by: Luma Al-Obaidy, et al.
Published: (2021-03-01)

Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case Report
by: Aslan Efendizade, et al.
Published: (2020-09-01)

The Effect of Heparin on Anterior Chamber Reaction in Pediatric Cataract Surgery
by: Yasir Iqbal, Sohail Zia, Aneeq Mirza
Published: (2011-12-01)